IVL-3004, a novel naltrexone-loaded microsphere formulation with improved PK and safety profile
Oct. 20, 2023
Researchers from Inventage Lab Inc. have presented preclinical data for its naltrexone-loaded microspheres, named IVL-3004, developed as long-acting injectable using the proprietary IVL-Drugfluidic technology platform.